Moody’s upgrades Fred Hutchison Cancer Research Center’s rating to ‘A2’

 
Moody’s Investors Service upgraded the long-term debt ratings for Seattle-based Fred Hutchison Cancer Research Center from “A3” to “A2,” affecting $352 million of debt.

Advertisement

The upgrade reflects the dramatic improvement in the cancer center’s unrestricted liquidity and growth in cash. The rating favorably reflects the organization’s national standing as a leading cancer research institute.

The rating outlook is stable.

More articles on healthcare finance:

Bankrupt hospital chain’s plan to offload 5 California clinics faces opposition
Attorney general investigating 2 Kansas hospitals that abruptly closed
Trinity Health posts $301M loss in first half of fiscal year

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-Metrix

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.